167 related articles for article (PubMed ID: 15059904)
1. Molecular classification and survival prediction in human gliomas based on proteome analysis.
Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A
Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904
[TBL] [Abstract][Full Text] [Related]
2. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of gliomas.
Whittle IR; Short DM; Deighton RF; Kerr LE; Smith C; McCulloch J
Br J Neurosurg; 2007 Dec; 21(6):576-82. PubMed ID: 18071984
[TBL] [Abstract][Full Text] [Related]
4. A unique four-hub protein cluster associates to glioblastoma progression.
Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S
PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814
[TBL] [Abstract][Full Text] [Related]
5. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification.
Le Rhun E; Duhamel M; Wisztorski M; Gimeno JP; Zairi F; Escande F; Reyns N; Kobeissy F; Maurage CA; Salzet M; Fournier I
Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):875-890. PubMed ID: 27890679
[TBL] [Abstract][Full Text] [Related]
7. Proteomic level changes associated with S3I201 treated U87 glioma cells.
Jain R; Atak A; Yeola A; Srivastava S
J Proteomics; 2017 Jan; 150():341-350. PubMed ID: 27565396
[TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery: a proteomic approach for brain cancer profiling.
Khalil AA
Cancer Sci; 2007 Feb; 98(2):201-13. PubMed ID: 17233837
[TBL] [Abstract][Full Text] [Related]
9. Investigation of serum proteome alterations in human glioblastoma multiforme.
Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S
Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992
[TBL] [Abstract][Full Text] [Related]
10. Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.
Iwadate Y; Sakaida T; Saegusa T; Hiwasa T; Takiguchi M; Fujimoto S; Yamaura A
Int J Oncol; 2005 Apr; 26(4):993-8. PubMed ID: 15753994
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors.
Zhang R; Tremblay TL; McDermid A; Thibault P; Stanimirovic D
Glia; 2003 Apr; 42(2):194-208. PubMed ID: 12655603
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of global effect of LLL12 on U87 cell's proteome: An insight into the molecular mechanism of LLL12.
Jain R; Kulkarni P; Dhali S; Rapole S; Srivastava S
J Proteomics; 2015 Jan; 113():127-42. PubMed ID: 25286751
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas.
Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T
J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731
[TBL] [Abstract][Full Text] [Related]
14. Proteomic studies on low- and high-grade human brain astrocytomas.
Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A
J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716
[TBL] [Abstract][Full Text] [Related]
15. Multifarious proteomic signatures and regional heterogeneity in glioblastomas.
Park CK; Jung JH; Park SH; Jung HW; Cho BK
J Neurooncol; 2009 Aug; 94(1):31-9. PubMed ID: 19219580
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K
Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970
[TBL] [Abstract][Full Text] [Related]
17. Combining laser capture microdissection and proteomics techniques.
Mustafa D; Kros JM; Luider T
Methods Mol Biol; 2008; 428():159-78. PubMed ID: 18287773
[TBL] [Abstract][Full Text] [Related]
18. iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
Rajcevic U; Petersen K; Knol JC; Loos M; Bougnaud S; Klychnikov O; Li KW; Pham TV; Wang J; Miletic H; Peng Z; Bjerkvig R; Jimenez CR; Niclou SP
Mol Cell Proteomics; 2009 Nov; 8(11):2595-612. PubMed ID: 19674965
[TBL] [Abstract][Full Text] [Related]
19. Slow Off-Rate Modified Aptamer (SOMAmer) Proteomic Analysis of Patient-Derived Malignant Glioma Identifies Distinct Cellular Proteomes.
Thanasupawat T; Glogowska A; Pascoe C; Krishnan SN; Munir M; Begum F; Beiko J; Krcek J; Del Bigio MR; Pitz M; Shen Y; Spicer V; Coombs KM; Wilkins J; Hombach-Klonisch S; Klonisch T
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502484
[TBL] [Abstract][Full Text] [Related]
20. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]